Piper Sandler Upgrades Moderna (MRNA) to Overweight

October 15, 2021 3:51 AM EDT
Get Alerts MRNA Hot Sheet
Price: $167.96 -4.99%

Rating Summary:
    8 Buy, 12 Hold, 1 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 8 | Down: 33 | New: 7
Join SI Premium – FREE

Piper Sandler analyst Edward Tenthoff upgraded Moderna (NASDAQ: MRNA) from Neutral to Overweight with a price target of $445.00.

For an analyst ratings summary and ratings history on Moderna click here. For more ratings news on Moderna click here.

Shares of Moderna closed at $331.88 yesterday.

You May Also Be Interested In

Related Categories